145 related articles for article (PubMed ID: 1373964)
21. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.
Melia WM; Wilkinson ML; Portmann BC; Johnson PJ; Williams R
Q J Med; 1984; 53(211):391-400. PubMed ID: 6207557
[TBL] [Abstract][Full Text] [Related]
22. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Taketa K; Sekiya C; Namiki M; Akamatsu K; Ohta Y; Endo Y; Kosaka K
Gastroenterology; 1990 Aug; 99(2):508-18. PubMed ID: 1694805
[TBL] [Abstract][Full Text] [Related]
23. Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
Harada T; Shigeta K; Noda K; Fukumoto Y; Nishimura H; Mizuta M; Takemoto T
Hepatogastroenterology; 1980 Jun; 27(3):169-75. PubMed ID: 6161869
[TBL] [Abstract][Full Text] [Related]
24. Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma.
Tanabe Y; Ohnishi K; Nomura F; Iida S
Am J Gastroenterol; 1988 Dec; 83(12):1386-9. PubMed ID: 2461655
[TBL] [Abstract][Full Text] [Related]
25. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Fabris C; Basso DA; Leandro G; Meggiato T; Elba S; Panozzo MP; Del Favero G; Fogar P; Di Mario F; Naccarato R
Cancer; 1991 Oct; 68(8):1795-8. PubMed ID: 1717126
[TBL] [Abstract][Full Text] [Related]
26. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
[TBL] [Abstract][Full Text] [Related]
27. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Chen DS; Sung JL; Sheu JC; Lai MY; How SW; Hsu HC; Lee CS; Wei TC
Gastroenterology; 1984 Jun; 86(6):1404-9. PubMed ID: 6201411
[TBL] [Abstract][Full Text] [Related]
28. Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.
Johnson PJ; Portmann B; Williams R
Br Med J; 1978 Sep; 2(6138):661-3. PubMed ID: 81086
[TBL] [Abstract][Full Text] [Related]
29. [Heterogeneity of alpha-fetoprotein with concanavalin A-binding properties in the serum and ascites of liver neoplasms and liver cirrhosis].
Fujise K; Nagamori S; Hasumura S; Homma S; Sujino H; Kameda H
Nihon Shokakibyo Gakkai Zasshi; 1983 Nov; 80(11):2363-8. PubMed ID: 6200631
[No Abstract] [Full Text] [Related]
30. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
Sarwar S; Khan AA; Tarique S
J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis].
Lee HY; Jung JH; Kang YS; Kim YS; Moon HS; Park KO; Lee YS; Kim SM; Seo SW; Lee SW; Kim SH; Lee BS; Kim NJ
Korean J Gastroenterol; 2004 Apr; 43(4):252-9. PubMed ID: 15100489
[TBL] [Abstract][Full Text] [Related]
32. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
[TBL] [Abstract][Full Text] [Related]
33. [Serum concentrations of alpha-1-fetoprotein suggestive of, or pathognomonic for hepatoma (author's transl)].
Polterauer P; Horak W; Legenstein E; Müller M
Wien Klin Wochenschr; 1979 Mar; 91(6):201-4. PubMed ID: 85372
[TBL] [Abstract][Full Text] [Related]
34. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
35. [Immunochemical determination of alpha-fetoprotein in the dynamics of development of liver cirrhosis and hepatocellular cancer].
Afanas'eva KA; Ragozin IuE; Tatarinov IuS
Vestn Akad Med Nauk SSSR; 1975; (6):71-3. PubMed ID: 58499
[No Abstract] [Full Text] [Related]
36. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
Melia WM; Johnson PJ; Neuberger J; Zaman S; Portmann BC; Williams R
Gastroenterology; 1984 Sep; 87(3):660-3. PubMed ID: 6204905
[TBL] [Abstract][Full Text] [Related]
37. Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Eleftheriou N; Heathcote J; Thomas HC; Sherlock S
J Clin Pathol; 1977 Aug; 30(8):704-8. PubMed ID: 74380
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J
Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228
[TBL] [Abstract][Full Text] [Related]
40. The significance of serum AFP cut-off values, 20 and 400 ng/mL in curatively resected patients with hepatocellular carcinoma and cirrhosis might be of difference.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2012 May; 59(115):840-3. PubMed ID: 22469729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]